Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle

Authors: Antoun, Sami, Lanoy, Emilie, Ammari, Samy, Farhane, Siham, Martin, Lisa, Robert, Caroline, Planchard, David, Routier, Emilie, Voisin, Anne Laure, Messayke, Sabine, Champiat, Stephane, Michot, Jean Marie, Laghouati, Salim, Lambotte, Olivier, Marabelle, Aurélien, Baracos, Vickie

Source: European journal of cancer. 178:49-59

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100177957897.0x000001&indx=1&recIds=ETOCvdc_100177957897.0x000001

Analysis of the association between prospectively collected immune-related adverse events and survival in patients with solid tumor treated with immune-checkpoint blockers, taking into account immortal-time bias

Authors: Kfoury, Maria, Najean, Marie, Lappara, Ariane, Voisin, Anne-Laure, Champiat, Stéphane, Michot, Jean-Marie, Laghouati, Salim, Robert, Caroline, Besse, Benjamin, Soria, Jean-Charles, Lambotte, Olivier, Massard, Christophe, Marabelle, Aurélien, Texier, Matthieu

Source: In Cancer Treatment Reviews November 2022 110

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

Authors: Ruste, Valentine, Goldschmidt, Vincent, Laparra, Ariane, Messayke, Sabine, Danlos, Francois-Xavier, Romano-Martin, Patricia, Champiat, Stéphane, Voisin, Anne-Laure, Baldini, Capucine, Massard, Christophe, Laghouati, Salim, Marabelle, Aurélien, Lambotte, Olivier, Michot, Jean-Marie

Source: In European Journal of Cancer November 2021 158:217-224

Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation

Authors: Ramos-Casals, Manuel, Mariette, Xavier, Lambotte, Olivier, Kostine, Marie, Khamashta, Munther A., Calabrese, Leonard, Suárez-Almazor, Maria, Baldini, Chiara, Bingham, Clifton O., Gottenberg, Jacques-Eric, Radstake, Timothy R.D., Schaeverbeke, Thierry, Schulze-Koops, Hendrik, Brito-Zerón, Pilar, Flores-Chávez, Alejandra, Acar-Denizli, Nihan, Chanson, Noémie, Pundole, Xerxes, Suijkerbuijk, Karijn, José de Barros e Silva, Milton, Lidar, Merav, Benesova, Karolina, Leipe, Jan, Pradère, Pauline, Michot, Jean-Marie, Voisin, Anne- Laure, Suárez-Almazor, Maria E., Fernandes Moça Trevisani, Virginia, Melin, Audrey, Robert, Caroline, Baughman, Robert P.

Source: In European Journal of Cancer November 2021 158:208-216

Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study

Authors: Cabanié, Charlotte, Ammari, Samy, Hans, Sophie, Pobel, Cedric, Laparra, Ariane, Danlos, Francois-Xavier, Chanson, Noémie, Dolidon, Samuel, Seban, Romain, Voisin, Anne-Laure, Pautier, Patricia, Romano-Martin, Patricia, Even, Caroline, Baldini, Capucine, Besse, Benjamin, Albiges, Laurence, Boutros, Celine, Routier, Emilie, Balleyguier, Corinne, De Montpreville, Vincent T., Champiat, Stéphane, Massard, Christophe, Robert, Caroline, Marabelle, Aurélien, Mateus, Christina, Lambotte, Olivier, Le Pavec, Jérôme, Michot, Jean-Marie

Source: In European Journal of Cancer October 2021 156:46-59

Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation

Authors: Chanson, Noémie, Ramos-Casals, Manuel, Pundole, Xerxes, Suijkerbuijk, Karijn, José de Barros e Silva, Milton, Lidar, Merav, Benesova, Karolina, Leipe, Jan, Acar-Denizli, Nihan, Pradère, Pauline, Michot, Jean-Marie, Voisin, Anne- Laure, Suárez-Almazor, Maria E., Radstake, Timothy R.D., Fernandes Moça Trevisani, Virginia, Schulze-Koops, Hendrik, Melin, Audrey, Robert, Caroline, Mariette, Xavier, Baughman, Robert P., Lambotte, Olivier

Source: European journal of cancer. 158:208-216

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100147836309.0x000001&indx=1&recIds=ETOCvdc_100147836309.0x000001

Infectious complications in patients treated with immune checkpoint inhibitors

Authors: Karam, Jean-Denis, Noel, Nicolas, Voisin, Anne-Laure, Lanoy, Emilie, Michot, Jean-Marie, Lambotte, Olivier

Source: In European Journal of Cancer December 2020 141:137-142

The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

Authors: Michot, Jean-Marie, Lappara, Ariane, Le Pavec, Jérôme, Simonaggio, Audrey, Collins, Michael, De Martin, Eléonora, Danlos, François-Xavier, Ammari, Samy, Cauquil, Cécile, Ederhy, Stéphane, Barreau, Emmanuel, Belkhir, Rakiba, Berdelou, Amandine, Lazarovici, Julien, Chanson, Philippe, Izzedine, Hassan, Seferian, Andrei, Le Pajolec, Christine, Baldini, Capucine, Martin-Romano, Patricia, Mariette, Xavier, Robert, Caroline, Besse, Benjamin, Hollebecque, Antoine, Varga, Andrea, Laghouati, Salim, Mateus, Christine, Voisin, Anne-Laure, Soria, Jean-Charles, Massard, Christophe, Marabelle, Aurélien, Champiat, Stéphane, Lambotte, Olivier

Source: In European Journal of Cancer May 2020 130:39-50

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

Authors: Baldini, Capucine, Martin Romano, Patricia, Voisin, Anne-Laure, Danlos, François-Xavier, Champiat, Stéphane, Laghouati, Salim, Kfoury, Maria, Vincent, Hélène, Postel-Vinay, Sophie, Varga, Andreea, Vuagnat, Perrine, Ribrag, Vincent, Mezquita, Laura, Besse, Benjamin, Hollebecque, Antoine, Lambotte, Olivier, Michot, Jean-Marie, Soria, Jean-Charles, Massard, Christophe, Marabelle, Aurélien

Source: In European Journal of Cancer April 2020 129:71-79

Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy

Authors: Bitton, Karen, Michot, Jean-Marie, Barreau, Emmanuel, Lambotte, Olivier, Haigh, Oscar, Marabelle, Aurélien, Voisin, Anne-Laure, Mateus, Christine, Rémond, Anne-Laure, Couret, Chloé, Champiat, Stéphane, Labetoulle, Marc, Rousseau, Antoine

Source: In American Journal of Ophthalmology June 2019 202:109-117

Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study

Authors: Babai, Samy, Voisin, Anne-Laure, Bertin, Célia, Gouverneur, Amandine, Le-Louet, Hervé

Source: Drug safety. 43(2):111-117

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161866883.0x000001&indx=1&recIds=ETOCvdc_100161866883.0x000001

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Authors: Delanoy, Nicolas, Michot, Jean-Marie, Comont, Thibault, Kramkimel, Nora, Lazarovici, Julien, Dupont, Romain, Champiat, Stéphane, Chahine, Claude, Robert, Caroline, Herbaux, Charles, Besse, Benjamin, Guillemin, Aude, Mateus, Christine, Pautier, Patricia, Saïag, Philippe, Madonna, Emanuela, Maerevoet, Marie, Bout, Jean-Christophe, Leduc, Charlotte, Biscay, Pascal, Quere, Gilles, Nardin, Charlée, Ebbo, Mikael, Albigès, Laurence, Marret, Grégoire, Levrat, Virginie, Dujon, Cécile, Vargaftig, Jacques, Laghouati, Salim, Croisille, Laure, Voisin, Anne-Laure, Godeau, Bertrand, Massard, Christophe, Ribrag, Vincent, Marabelle, Aurélien, Michel, Marc, Lambotte, Olivier

Source: In The Lancet Haematology January 2019 6(1):e48-e57

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

Authors: Danlos, François-Xavier, Voisin, Anne-Laure, Dyevre, Valérie, Michot, Jean-Marie, Routier, Emilie, Taillade, Laurent, Champiat, Stéphane, Aspeslagh, Sandrine, Haroche, Julien, Albiges, Laurence, Massard, Christophe, Girard, Nicolas, Dalle, Stéphane, Besse, Benjamin, Laghouati, Salim, Soria, Jean-Charles, Mateus, Christine, Robert, Caroline, Lanoy, Emilie, Marabelle, Aurélien, Lambotte, Olivier

Source: In European Journal of Cancer March 2018 91:21-29

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

Authors: Le Burel, Sébastien, Champiat, Stéphane, Mateus, Christine, Marabelle, Aurélien, Michot, Jean-Marie, Robert, Caroline, Belkhir, Rakiba, Soria, Jean-Charles, Laghouati, Salim, Voisin, Anne-Laure, Fain, Olivier, Mékinian, Arsène, Coutte, Laetitia, Szwebel, Tali-Anne, Dunogeant, Laetitia, Lioger, Bertrand, Luxembourger, Cécile, Mariette, Xavier, Lambotte, Olivier

Source: In European Journal of Cancer September 2017 82:34-44

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies

Authors: Bernard-Tessier, Alice, Jeanville, Priscilla, Champiat, Stéphane, Lazarovici, Julien, Voisin, Anne-Laure, Mateus, Christine, Lambotte, Olivier, Annereau, Maxime, Michot, Jean-Marie

Source: European journal of cancer. 81:135-137

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100063326992.0x000001&indx=1&recIds=ETOCvdc_100063326992.0x000001

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Authors: Manson, Guillaume, Maria, Alexandre Thibault Jacques, Poizeau, Florence, Danlos, François-Xavier, Kostine, Marie, Brosseau, Solenn, Aspeslagh, Sandrine, Du Rusquec, Pauline, Roger, Maxime, Pallix-Guyot, Maud, Ruivard, Marc, Dousset, Léa, Grignou, Laurianne, Psimaras, Dimitri, Pluvy, Johan, Quéré, Gilles, Grados, Franck, Duval, Fanny, Bourdain, Frederic, Maigne, Gwenola, Perrin, Julie, Godbert, Benoit, Taifas, Beatris Irina, Forestier, Alexandra, Voisin, Anne-Laure, Martin-Romano, Patricia, Baldini, Capucine, Marabelle, Aurélien, Massard, Christophe, Honnorat, Jérôme, Lambotte, Olivier, Michot, Jean-Marie

Source: Journal for immunotherapy of cancer. 7(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132527528.0x000001&indx=1&recIds=ETOCvdc_100132527528.0x000001

Letter responds to the comment in 'immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty'

Authors: Michot, Jean-Marie, Lazarovici, Julien, Tieu, Ashley, Champiat, Stéphane, Voisin, Anne-Laure, Ebbo, Mikael, Godeau, Bertrand, Michel, Marc, Ribrag, Vincent, Lambotte, Olivier

Source: European journal of cancer. 134:60-61

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115803241.0x000001&indx=1&recIds=ETOCvdc_100115803241.0x000001

Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.

Authors: Plaçais, Léo, Michot, Jean-Marie, Champiat, Stéphane, Romano-Martin, Patricia, Baldini, Capucine, Joao, Maria Silva, Marabelle, Aurélien, Voisin, Anne-Laure, Not, Adeline, Labeyrie, Céline, Beaudonnet, Guillemette, Laparra, Ariane, Maria, Alexandre T. J., Masseau, Agathe, Dehette, Stéphanie, Deleporte, Amélie, Echaniz-Laguna, Andoni, Denier, Christian, Adams, David, Lambotte, Olivier

Source: Brain Communications; 2021, Vol. 3 Issue 4, p1-13, 13p

Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.

Authors: Simonaggio, Audrey, Michot, Jean Marie, Voisin, Anne Laure, Le Pavec, Jérome, Collins, Michael, Lallart, Audrey, Cengizalp, Geoffray, Vozy, Aurore, Laparra, Ariane, Varga, Andréa, Hollebecque, Antoine, Champiat, Stéphane, Marabelle, Aurélien, Massard, Christophe, Lambotte, Olivier

Source: JAMA Oncology; Sep2019, Vol. 5 Issue 9, p1310-1317, 8p

This result is not displayed to guests.
Login for full access.